Cancer
Genomic testing offers personalised treatment for patients with myeloid blood cancers
Round 1
Following a granting process in late 2016, an investment of $4.8 million was awarded to Round 1 projects in April 2017.
In Round 1, Queensland Genomics program design was based on:
- The conduct of a number of clinical projects in specific disease areas;
- The concurrent establishment of five capability-building projects to build capability in key areas of the health system.
Round 1 clinical and capability-building projects ran from September 2017 until March 2019.
Clinical demonstration projects
The objective of the Round 1 clinical projects was to evaluate the use of genomic sequencing to diagnose and manage patients in specific disease areas.
Four disease areas were selected as clinical projects in Round 1:
Capability building
A core theme of Queensland Genomics’ objectives is to build capability and infrastructure to implement clinical genomics in Queensland healthcare.
We invested in five capability-building projects in Round 1:
Genomic Workforce Development
Evaluation of Clinical Genomics
Genomic Testing Innovation
Genomic Information Management
Ethics, Legal and Social Implications of Genomics
